Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110527646B reveals a novel Bacillus tropicalis strain for high-purity S-isomer production. Discover cost-effective agrochemical intermediate manufacturing solutions.
Patent CN100344766C details a cost-effective enzymatic resolution of 2-methyl-1-butanol using vinyl acetate, offering significant supply chain advantages for pharmaceutical intermediates.
Patent CN101333554B reveals enzymatic resolution for D-lactic acid. Achieve high optical purity and cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalysis.
Patent CN1277807C details a novel metal hydride reduction route for carbocyclic nucleoside intermediates, offering significant cost reduction and scalable manufacturing capabilities.
Novel diazotization process for D-amino acids reduces enzyme use and cost. Reliable supplier for pharma intermediates with scalable production.
Patent CN100392090C details a novel enzymatic resolution for L/D-Methionine-15N. Achieve high isotopic abundance and optical purity with scalable biocatalytic processes.
Patent CN1062604C details enzymatic DL-Methionine resolution. Achieves high yield and purity. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN114621986B reveals enzymatic synthesis for optically pure Taxol side chains. Discover cost-effective, scalable manufacturing solutions for pharmaceutical intermediates.
Patent CN114921507B reveals lipase resolution for 2-oxabicyclo-[3.3.0]oct-6-en-3-one. High purity, green process, reliable supply chain for pharmaceutical intermediates.
Novel enzymatic resolution route for high-purity Alzheimer's intermediate. Reduces cost and improves scalability for pharma manufacturing.
Patent CN114891838B reveals enzymatic resolution for dorzolamide intermediate. Achieve high purity and cost efficiency with scalable manufacturing processes.
Patent CN101104861B reveals a novel Yarrowia lipolytica lipase method for S-ibuprofen. Discover cost-effective, high-selectivity biocatalysis for pharmaceutical manufacturing.
High-purity S-tetrahydrofuranic acid via enzymatic resolution. Superior yield and optical purity for pharmaceutical intermediates supply chain.
Novel enzymatic process for high-purity D-tryptophan. Reduces cost and ensures supply continuity for pharmaceutical manufacturing.
Patent CN103074409A details a novel enzymatic resolution method for high-purity halogenated alpha-amino acids, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN102994470A details a novel Aus EH-B enzyme for high-purity chiral epichlorohydrin. Discover cost-effective biocatalytic solutions for pharmaceutical intermediates.
Novel enzymatic resolution method for ambrisentan reduces solvent use and improves yield. Ideal for reliable API intermediate supplier partnerships.
Patent CN111363736A reveals a novel enzymatic route for dexketoprofen using Klebsiella amidase, offering superior ee values and greener manufacturing for pharmaceutical intermediates.
Patent CN109180496B details a novel lipase-catalyzed resolution and Mitsunobu reaction for Cinacalcet. Achieve high purity without hazardous reducing agents.
Patent CN101974604B details a novel ionic liquid biocatalysis route for paroxetine intermediates, offering high optical purity and reduced environmental impact for reliable supply chains.